Rhythm Pharmaceuticals In... (RYTM)
51.97
1.97 (3.94%)
At close: Apr 02, 2025, 3:59 PM
Rhythm Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 89.14M | 60.08M | 127.68M | 59.25M | 100.85M | 62.29M | 49.54M | 34.24M | 6.54M | 34.87M | 152K | 7.36M | 11.77M |
| Short-Term Investments | 231.43M | 215.76M | 205.61M | 235.61M | 71.94M | 230.16M | 202.52M | 113.85M | 4M | n/a | n/a | 10.4M | 5.27M |
| Long-Term Investments | n/a | n/a | 328K | 328K | 403K | 403K | 401K | 225K | 225K | 285K | n/a | n/a | n/a |
| Other Long-Term Assets | 7.79M | 15.33M | 16.98M | 12.14M | n/a | n/a | n/a | n/a | 9K | 1.48M | n/a | 23K | 23K |
| Receivables | 18.51M | 14.87M | 6.22M | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | 18.74M | 8.62M | 2.92M | 111K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 16.38M | 6.67M | 11.81M | 3.99M | 8.88M | 9.95M | 6.63M | 2.59M | 216K | 28K | 42K | n/a | n/a |
| Total Current Assets | 374.2M | 308.27M | 354.24M | 308.39M | 181.67M | 302.4M | 258.69M | 150.67M | 11.18M | 35.49M | 194K | 18.14M | 18.86M |
| Property-Plant & Equipment | 4.11M | 2.12M | 3.38M | 4.33M | 5M | 5.72M | 1.12M | 840K | 930K | 17K | n/a | 24K | 44K |
| Goodwill & Intangibles | 6.17M | 7.03M | 7.88M | 4.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 18.07M | 24.48M | 28.25M | 21.14M | 5.41M | 6.12M | 1.52M | 1.06M | 1.16M | 1.78M | n/a | 47K | 67K |
| Total Assets | 392.27M | 332.75M | 382.48M | 329.52M | 187.07M | 308.52M | 260.21M | 151.74M | 12.34M | 37.27M | 194K | 18.19M | 18.92M |
| Account Payables | 12.33M | 4.88M | 4.8M | 5.74M | 4.9M | 10.41M | 7.64M | 2.43M | 1.9M | 1.43M | 535K | 1.47M | 2.25M |
| Deferred Revenue | 1.29M | 1.29M | 1.43M | 7M | 12.38M | 13.15M | n/a | n/a | n/a | 249K | n/a | n/a | n/a |
| Short-Term Debt | n/a | n/a | 684K | 606K | 535K | 472K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 101.9M | 32.82M | 20.77M | 21.11M | -355K | -95K | n/a | 83K | 76K | 44K | n/a | 1.34M | 255K |
| Total Current Liabilities | 115.52M | 55.2M | 39.81M | 43.43M | 17.99M | 24.42M | 13.58M | 6.72M | 4.73M | 5.27M | 552K | 3.06M | 2.5M |
| Long-Term Debt | 3.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 108.27M | 107.29M | 77.15M | n/a | n/a | n/a | 372K | 228K | 311K | n/a | n/a | 72.59M | 52.7M |
| Total Long-Term Liabilities | 112.21M | 107.78M | 78.41M | 1.95M | 2.55M | 3.09M | 372K | 228K | 311K | n/a | n/a | 72.59M | 52.7M |
| Total Liabilities | 227.72M | 162.99M | 118.22M | 45.37M | 20.55M | 27.5M | 13.95M | 6.95M | 5.04M | 5.27M | 552K | 75.65M | 55.21M |
| Total Debt | 3.94M | 1.26M | 1.94M | 2.55M | 3.09M | 3.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 61K | 59K | 56K | 50K | 44K | 44K | 34K | 27K | 10K | 10K | 93K | 53K | 3K |
| Retained Earnings | -1.16B | -894.74M | -710.06M | -528.94M | -459.33M | -325.33M | -184.6M | -110.25M | -76.54M | -50.67M | -39.6M | -58.44M | -37.01M |
| Comprehensive Income | -39K | 134K | -92K | -1K | 49K | n/a | -809K | -367K | -144K | n/a | n/a | -46K | -26K |
| Shareholders Equity | 21.73M | 169.76M | 264.26M | 284.15M | 166.53M | 281.02M | 246.26M | 144.79M | 7.3M | 32M | -358K | -57.46M | -36.28M |
| Total Investments | 231.43M | 215.76M | 205.61M | 235.61M | 71.94M | 230.16M | 202.52M | 113.85M | 4M | 285K | n/a | 10.4M | 5.27M |